Migration of dendritic cells into lymphatics - The Langerhans cell example: Routes, regulation, and relevance

International Review of Cytology

Volumn 207, Issue , 2001, Pages 237-270

  Romani, Nikolaus ^a   Ratzinger, Gudrun ^a   Pfaller, Kristian ^b   Salvenmoser, Willi ^b   Stössel, Hella ^a   Koch, Franz ^a   Stoitzner, Patrizia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cytokines; Dendritic cells; Electron microscopy; Langerhans cells; Migration

Indexed keywords

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; CELL MIGRATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; HUMAN; IMMUNE RESPONSE; LANGERHANS CELL; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0035010415     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(01)07007-3     Document Type: Article

References (176)

1. Aiba, S., and Katz, S. I. (1990). Phenotypic and functional characteristics of in vivo activated Langerhans cells. J. Immunol. 145, 2791-2796.
2. Aiba, S., Nakagawa, S., Ozawa, H., Miyake, K., Yagita, H., and Tagami, H. (1993). Upregulation of 4 integrin on activated Langerhans cells: Analysis of adhesion molecules on Langerhans cells relating to their migration from skin to draining lymph nodes. J. Invest. Dermatol. 100, 143-147.
3. Austyn, J. M. (1996). New insights into the mobilization and phagocytic activity of dendritic cells. J. Exp. Med. 183, 1287-1292.
4. Austyn, J. M., Kupiec-Weglinski, J. W., Hankins, D. F., and Morris, P. J. (1988). Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen and binding within marginal zone. J. Exp. Med. 167, 646-651.
5. Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature (Lond.) 392, 245-252.
6. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. T., Pulendran, B., and Palucka, K. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
7. Bell, D., Young, J. W., and Banchereau, J. (1999a). Dendritic cells. Adv. Immunol. 72, 255-324.
8. Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., and Banchereau, J. (1999b). In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. 190, 1417-1425.
9. Bergstresser, P. R., Toews, G. B., and Streilein, J. W. (1980). Natural and perturbed distributions of Langerhans cells: Responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization. J. Invest. Dermatol. 75, 73-77.
10. Birbeck, M. S., Breathnach, A. S., and Everall, J. D. (1961). An electron microscopic study of basal melanocytes and high level clear cells (Langerhans cell) in vitiligo. J. Invest. Dermatol. 37, 51-64.
11. Blank, C., Fuchs, H., Rappersberger, K., Röllinghoff, M., and Moll, H. (1993). Parasitism of epidermal Langerhans cells in experimental cutaneous Leishmaniasis with Leishmania major. J. Infect. Dis. 167, 418-425.
12. Blauveit, A., Katz, S. I., and Udey, M. C. (1995). Human Langerhans cells express E-cadherin. J. Invest. Dermatol. 104, 293-296.
13. Bodmer, S., Strommer, K., Frei, K., Siepl, C., De Tribolet, N., Heid, I., and Fontana, A. (1989). Immunosuppression and transforming growth factor-β in glioblastoma. Preferential production of transforming growth factor-β 2. J. Immunol. 143, 3222-3229.
14. Borkowski, T. A., Van Dyke, B. J., Schwarzenberger, K., McFarland, V. W., Fair, A. G., and Udey, M. C. (1994). Expression of E-cadherin by murine dendritic cells: E-cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells. Eur. J. Immunol. 24, 2767-2774.
15. Borkowski, T. A., Letterio, J. J., Farr, A. G., and Udey, M. C. (1996). A role for endogenous transforming growth factor-β 1 in Langerhans cell biology: The skin of transforming growth factor-β 1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184, 2417-2422.
16. Borkowski, T. A., Letterio, J. J., Mackall, C. L., Saitoh, A., Wang, X. J., Roop, D. R., Gress, R. E., and Udey, M. C. ( 1997). A role for TGF 1 in Langerhans cell biology - Further characterization of the epidermal Langerhans cell defect in TGF 1 null mice. J. Clin. Invest. 100, 575-581.
17. Botham, P. A., Rattray, N. J., Walsh, S. T., and Riley, E. J. (1987). Control of the immune response to contact sensitizing chemicals by cutaneous antigen-presenting cells. Br. J. Dermatol. 117, 1-9.
18. Carramolino, L., Kremer, L., Goya, I., Varona, R., Buesa, J. M., Gutiérrez, J., Zaballos, A., Martínez, A., and Márquez, G. (1999). Down-regulation of the chemokine receptor CCR6 in dendritic cells mediated by TNF-α and IL-4. J. Leukocyte Biol. 66, 837-844.
19. Caux, C., Dezutter-Dambuyant, C., Schmitt, D., and Banchereau, J. (1992). GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature (Lond.) 360, 258-261.
20. Caux, C., Vanbervliet, B., Massacrier, C., Azuma, M., Okumura, K., Lanier, L. L., and Banchereau, J. (1994). B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180, 1841-1847.
21. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF-α J. Exp. Med. 184, 695-706.
22. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor-α. 2. Functional analysis. Blood 90, 1458-1470.
23. Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T., and Falo, L. D. (1996). Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283-287.
24. Chapman, H. A. (1997). Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9, 714-724.
25. Charbonnier, A. S., Kohrgruber, N., Kriehuber, E., Stingl, G., Rot, A., and Maurer, D. (1999). Macrophage inflammatory protein 3 is involved in the constitutive trafficking of epidermal Langerhans cells. J. Exp. Med. 190, 1755-1767.
26. Chen, Q., Daniel, V., Maher, D. W., and Hersey, P. (1994). Production of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer 56, 755-760.
27. Cumberbatch, M., Fielding, I., and Kimber, I. (1994). Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-α. Immunology 81, 395-401.
28. Cumberbatch, M., Griffiths, C. E., Tucker, S. C., Dearman, R. J., and Kimber, I. (1999). Tumour necrosis factor-alpha induces Langerhans cell migration in humans. Br. J. Dermatol. 141, 192-200.
29. Cyster, J. G. (1999). Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med. 189, 447-450.
30. De Saint-Vis, B., Fugier-Vivier, I., Massacrier, C., Gaillard, C., Vanbervliet, B., Aït-Yahia, S., Banchereau, J., Liu, Y. J., Lebecque, S., and Caux, C. (1998). The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160, 1666-1676.
31. Dieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., and Caux, C. (1998). Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386.
32. Dieu-Nosjean, M. C., Massacrier, C., Homey, B., Vanbervliet, B., Pin, J. J., Vicari, A., Lebecque, S., Dezutter-Dambuyant, C., Schmitt, D., Zlotnik, A., and Caux, C. (2000). Macrophage inflammatory protein-3 alpha is expressed at inflamed epithelial surfaces, and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192, 705-718.
33. Duijvestijn, A. M., and Kamperdijk, E. W. A. (1982). Birbeck granules in interdigitating cells of thymus and lymph node. (abstract). Cell Biol. Int. Rep. 6, 655.
34. Dummer, W., Bastian, B. C., Ernst, N., Schänzle, C., Schwaaf, A., and Bröcker, E. B. (1996). Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int. J. Cancer 66, 607-610.
35. Ebner, S., Lenz, A., Reider, D., Fritsch, P., Schuler, G., and Romani, N. (1998). Expression of maturation-/migration-related molecules on human dendritic cells from blood and skin. Immunobiology 198, 568-587.
36. Egeler, R. M., and Nesbit, M. E. (1995). Langerhans cell histiocytosis and other disorders of monocyte-histiocyte lineage. Crit. Rev. Oncol. Hematol. 18, 9-35.
37. Enk, A. H., and Katz, S. I. (1992). Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA 89, 1398-1402.
38. Enk, A. H., Angeloni, V. L., Udey, M. C., and Katz, S. I. (1993). An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J. Immunol. 150, 3698-3704.
39. Esche, C., Subbotin, V. M., Hunter, O., Peron, J. M., Maliszewski, C., Lotze, M. T., and Shurin, M. R. (1999). Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligand. J. Invest. Dermatol. 113, 1028-1032.
40. + precursors and is down-regulated upon maturation. J. Immunol. 164, 712-718.
41. Fong, L., and Engleman, E. G. (2000). Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18, 245-273.
42. Fossum, S. (1988). Lymph-borne dendritic leucocytes do not recirculate, but enter the lymph node paracortex to become interdigitating cells. Scand. J. Immunol. 27, 97-106.
43. Friedl, P., Zanker, K. S., and Bröcker, E. B. (1998). Cell migration strategies in 3-D extracellular matrix: Differences in morphology, cell matrix interactions, and integrin function. Microsc. Res. Tech. 43, 369-378.
44. Fushimi, T., Kojima, A., Moore, M. A. S., and Crystal, R. G. (2000). Macrophage inflammatory protein 3α transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. J. Clin. Invest. 105, 1383-1393.
45. Gabrilovich, D. I., Chen, H. L., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., and Carbone, D. P. (1996). Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med. 2, 1096-1103.
46. Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., Van Vliet, S. J., Van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., Figdor, C. G., and Van Kooyk, Y. (2000a). DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances fraru-infection of T cells. Cell 100, 587-597.
47. Geijtenbeek, T. B. H., Torensma, R., Van Vliet, S. J., Van Duijnhoven, G. C. F., Adema, G. J., Van Kooyk, Y., and Figdor, C. G. (2000b). Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585.
48. Geissmann, F., Emile, J. F., Andry, P., Thomas, C., Fraitag, S., De Prost, Y., and Brousse, N. (1997). Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J. Pathol. 181, 301-304.
49. Goldman, S. A., Baker, E., Weyant, R. J., Clarke, M. R., Myers, J. N., and Lotze, M. T. (1998). Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Arch. Otolaryngol. Head Neck Surg. 124, 641-646.
50. Gunzer, M., Friedl, P., Niggemann, B., Bröcker, E. B., Kämpgen, E., and Zänker, K. S. (2000). Migration of dendritic cells within 3-D collagen lattices is dependent on tissue origin, state of maturation, and matrix structure and is maintained by proinflammatory cytokines. J. Leukocyte Biol. 67, 622-629.
51. Hart, D. N. J. (1997). Dendritic cells: Unique leukocyte populations which control the primary immune response. Blood 90, 3245-3287.
52. Heufler, C., Koch, F., and Schuler, G. (1988). Granulocyte-macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167, 700-705.
53. Hoefakker, S., Balk, H. P., Boersma, W. J. A., Van Joost, T., Notten, W. R. F., and Claassen, E. (1995). Migration of human antigen-presenting cells in a human skin graft onto nude mice model after contact sensitization. Immunology 86, 296-303.
54. Huang, F. P., Platt, N., Wykes, M., Major, J. R., Powell, T. J., Jenkins, C. D., and MacPherson, G. G. (2000). A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191, 435-443.
55. Inaba, K., Metlay, J. P., Crowley, M. T., and Steinman, R. M. (1990). Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172, 631-640.
56. Inaba, K., Steinman, R. M., Pack, M. W., Aya, H., Inaba, M., Sudo, T., Wolpe, S., and Schuler, G. (1992). Identification of proliferating dendritic cell precursors in mouse blood. J. Exp. Med. 175, 1157-1167.
57. Inaba, K., Inaba, M., Deguchi, M., Hagi, K., Yasumizu, R., Ikehara, S., Muramatsu, S., and Steinman, R. M. (1993). Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA 90, 3038-3042.
58. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M., Subklewe, M., Sauter, B., Sheff, D., Albert, M., Bhardwaj, N., Mellman, I., and Steinman, R. M. (1998). Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188, 2163-2173.
59. Inaba, K., Turley, S., Iyoda, T., Yamaide, F., Shimoyama, S., Sousa, C. R. E., Germain, R. N., Mellman, I., and Steinman, R. M. (2000). The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191, 927-936.
60. + subset of human blood dendritic cells is a direct precursor of Langerhans cells. J. Immunol. 163, 1409-1419.
61. Jakob, T., Brown, M. J., and Udey, M. C. (1999). Characterization of E-cadherin-containing junctions involving skin-derived dendritic cells. J. Invest. Dermatol. 112, 102-108.
62. Jiang, W., Swiggard, W. J., Heufler, C., Peng, M., Mirza, A., Steinman, R. M., and Nussenzweig, M. C. (1995). The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature (Lond.) 375, 151-155.
63. Josien, R., Li, H. L., Ingulli, E., Sarma, S., Wong, B. R., Vologodskaia, M., Steinman, R. M., and Choi, Y. (2000). TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo. J. Exp. Med. 191, 495-501.
64. Kamperdijk, E. W. A., Raaymakers, E. M., de Leeuw, J. H. S., and Hoefsmit, E. C. M. (1978). Lymph node macrophages and reticulum cells in the immune response. I. The primary response to parathyphoid vaccine. Cell Tissue Res. 192, 1-23.
65. Kashihara, M., Ueda, M., Horiguchi, Y., Furukawa, F., Hanaoka, M., and Imamura, S. (1986). A monoclonal antibody specifically reactive to human Langerhans cells. J. Invest. Dermatol. 87, 602-612.
66. Kellermann, S. A., Hudak, S., Oldham, E. R., Liu, Y. J., and McEvoy, L. M. (1999). The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3β are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J. Immunol. 162, 3859-3864.
67. Kimber, I., Cumberbatch, M., Dearman, R. J., Bhushnan, M., and Griffiths, C. E. M. (2000). Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br. J. Dermatol. 142, 401-412.
68. Kobayashi, Y., Staquet, M.-J., Dezutter-Dambuyant, C., and Schmitt, D. (1994). Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact. Eur. J. Immunol. 24, 2254-2257.
69. Kobayashi, Y., Matsumoto, M., Kotani, M., and Makino, T. (1999). Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 163, 5989-5993.
70. Koch, F., Heufler, C., Kämpgen, E., Schneeweiss, D., Böck, G., and Schuler, G. (1990). Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture but in contrast to granulocyte/macrophage colony-stimulating factor without inducing their functional maturation. J. Exp. Med. 171, 159-171.
71. Koch, F., Kämpgen, E., Schuler, G., and Romani, N. (2001). Isolation, enrichment and culture of murine epidermal Langerhans cells. In "Dendritic Cell Protocols" (A. J. Stagg and S. Robinson Eds.) in press. Humana Press, Totowa, NJ.
72. Kondo, M., Scherer, D. C., Miyamoto, T., King, A. G., Akashi, K., Sugamura, K., and Weissman, I. L. (2000). Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature (Lond.) 407, 383-386.
73. Kripke, M. L., Munn, C. G., Jeevan, A., Tang, J.-M., and Bucana, C. (1990). Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145, 2833-2838.
74. Krueger, G. G., Daynes, R. A., and Mansoor, E. (1983). Biology of Langerhans cells: Selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice. Proc. Natl. Acad. Sci. USA 80, 1650-1654.
75. Langerhans, P. (1868). Über die Nerven der menschlichen Haut. Virchows Arch. [A] 44, 325-337.
76. Lappin, M. B., Weiss, J. M., Delattre, V., Mai, B., Dittmar, H., Maier, C., Manke, K., Grabbe, S., Martin, S., and Simon, J. C. (1999). Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology 98, 181-188.
77. Larsen, C. P., Steinman, R. M., Witmer-Pack, M., Hankins, D. F., Morris, P. J., and Austyn, J. M. (1990). Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172, 1483-1493.
78. Lebre, M. C., Kalinski, P., Das, P. K., and Everts, V. (1999). Inhibition of contact sensitizerinduced migration of human Langerhans cells by matrix metalloproteinase inhibitors. Arch. Dermatol. Res. 291, 447-452.
79. Lenz, A., Heine, M., Schuler, G., and Romani, N. (1993). Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 92, 2587-2596.
80. Lieberman, P. H., Jones, C. R., Steinman, R. M., Erlandson, R. A., Smith, J., Gee, T., Huvos, A., Garin-Chesa, P., Filippa, D. A., Urmacher, C., Gangi, M. D., and Sperber, M. (1996). Langerhans cell (eosinophilic) granulomatosis - A clinicopathologic study encopassing 50 years. Am. J. Surg. Pathol. 20, 519-552.
81. Lotze, M. T., and Thomson, A. W. (Eds.) (1999). "Dendritic Cells: Biology and Clinical Applications." Academic Press, San Diego.
82. Lotze, M. T., and Thomson, A. W. (Eds.) (2001). "Dendritic Cells: Biology and Clinical Applications," 2 Ed. Academic Press, San Diego.
83. Lukas, M., Stössel, H., Hefel, L., Imamura, S., Fritsch, P., Sepp, N. T., Schuler, G., and Romani, N. (1996). Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J. Invest. Dermatol. 106, 1293-1299.
84. Macatonia, S. E., Knight, S. C., Edwards, A. J., Griffiths, S., and Fryer, P. (1987). Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J. Exp. Med. 166, 1654-1667.
85. Matsuno, K., and Ezaki, T. (2000). Dendritic cell dynamics in the liver and hepatic lymph. Int. Rev. Cytol. 197, 83-136.
86. Maurer, D., and Stingl, G. (1999). Dendritic cells in the context of skin immunology. In "Dendritic Cells: Biology and Clinical Applications." (M. T. Lotze and A. W. Thomson Eds.), pp. 111-122. Academic Press, San Diego.
87. Moll, H., Fuchs, H., Blank, C., and Röllinghoff, M. (1993). Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23, 1595-1601.
88. Moll, H. (Ed.) (1995). "The Immune Functions of Epidermal Langerhans Cells," pp. 1-193. Springer-Verlag, Berlin.
89. Moodycliffe, A. M., Shreedhar, V., Ullrich, S. E., Walterscheid, J., Bucana, C., Kripke, M. L., and Flores-Romo, L. (2000). CD40-CD40 ligand interactions in vivo regulate migration of antigen-bearing dendritic cells from the skin to draining lymph nodes. J. Exp. Med. 191, 2011-2020.
90. Morse, M. A., and Lyerly, H. K. (1999). Dendritic cell-based immunization for cancer therapy. Adv. Exp. Med. Biol. 465, 335-346.
91. Morse, M. A., Coleman, R. E., Akabani, G., Niehaus, N., Coleman, D., and Lyerly, H. K. (1999). Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59, 56-58.
92. Murphy, G., and Gavrilovic, J. (1999). Proteolysis and cell migration: Creating a path? Curr. Opin. Cell Biol. 11, 614-621.
93. Nestle, F. O., Zheng, X.-G., Thompson, C. B., Turka, L. A., and Nickoloff, B. J. (1993). Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 151, 6535-6545.
94. Ortner, U., Inaba, K., Koch, F., Heine, M., Miwa, M., Schuler, G., and Romani, N. (1996). An improved isolation method for murine migratory cutaneous dendritic cells. J. Immunol. Methods 193, 71-79.
95. Peeler, J. S., and Niederkorn, J. Y. (1987). Effect of Langerhans cells on cytotoxic lymphocyte-T responses to major and minor alloantigens expressed on heterotopic corneal allografts. Transplantation Proc. 19, 316-320.
96. Pope, M., Betjes, M. G. H., Hirmand, H., Hoffman, L., and Steinman, R. M. (1995). Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. J. Invest. Dermatol. 104, 11-17.
97. 6 integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 186, 1725-1735.
98. Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., and Maliszewski, C. R. (1999). Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96, 1036-1041.
99. Rambukkana, A., Pistoor, F. H. M., Bos, J. D., Kapsenberg, M. L., and Das, P. K. (1996). Effects of contact allergens on human Langerhans cells in skin organ culture: Migration, modulation of cell surface molecules, and early expression of interleukin-1β protein. Lab. Invest. 74, 422-436.
100. Randolph, G. J., Beaulieu, S., Pope, M., Sugawara, I., Hoffman, L., Steinman, R. M., and Muller, W. A. (1998a). A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. USA 95, 6924-6929.
101. Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M., and Muller, W. A. (1998b). Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480-483.
102. Randolph, G. J., Inaba, K., Robbiani, D. F., Steinman, R. M., and Muller, W. A. (1999). Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11, 753-761.
103. Ratzinger, G., Stoitzner, P., Lutz, M. B., Schuler, G., Senior, R. M., Shipley, J. M., Fritsch, P., and Romani, N. (2000). Effect of matrix metalloproteinases on the migration of murine cutaneous dendritic cells (abstract). Arch. Dermatol. Res. 292, 74.
104. Rissoan, M. C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., Malefyt, R. D., and Liu, Y. J. (1999). Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186.
105. Roake, J. A., Rao, A. S., Morris, P. J., Larsen, C. P., Hankins, D. F., and Austyn, J. M. (1995). Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181, 2237-2248.
106. Robbiani, D. F., Finch, R. A., Jäger, D., Muller, W. A., Sartorelli, A. C., and Randolph, G. J. (2000). The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103, 757-768.
107. Robert, C., Fuhlbrigge, R. C., Kieffer, J. D., Ayehunie, S., Hynes, R. O., Cheng, G. Y., Grabbe, S., Von Andrian, U. H., and Kupper, T. S. (1999). Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance. J. Exp. Med. 189, 627-635.
108. Romani, N., Inaba, K., Pure, E., Crowley, M., Witmer-Pack, M., and Steinman, R. M. (1989a). A small number of anti-CD3 molecules on dendritic cells stimulates DNA synthesis in mouse T lymphocytes. J. Exp. Med. 169, 1153-1168.
109. Romani, N., Lenz, A., Glassei, H., Stössel, H., Stanzl, U., Majdic, O., Fritsch, P., and Schuler, G. (1989b). Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J. Invest. Dermatol. 93, 600-609.
110. Romani, N., Koide, S., Crowley, M., Witmer-Pack, M., Livingstone, A. M., Fathman, C. G., Inaba, K., and Steinman, R. M. (1989c). Presentation of exogenous protein antigens by dendritic cells to T cell clones: Intact protein is presented best by immature epidermal Langerhans cells. J. Exp. Med. 169, 1169-1178.
111. Romani, N., Witmer-Pack, M., Crowley, M., Koide, S., Schuler, G., Inaba, K., and Steinman, R. M. (1991). Langerhans cells as immature dendritic cells. In "Epidermal Langerhans Cells" (G. Schuler, Ed.), pp. 191-216. CRC Press, Inc., Boca Raton, FL.
112. Romani, N., Gruner, S., Brang, D., Kämpgen, F., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., and Schuler, G. (1994). Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83-93.
113. Romani, N., Bhardwaj, N., Pope, M., Koch, F., Swiggard, W. J., O'Doherty, U., Witmer-Pack, M. D., Hoffman, L., Schuler, G., Inaba, K., and Steinman, R. M. (1997). Dendritic Cells. In "Weir's Handbook of Experimental Immunology," 5th Ed. (L. A. Herzenberg, D. M. Weir, L. Herzenberg, and C. Blackwell, Eds.), pp. 156. 1-156.14. Blackwell Science, Oxford.
114. Rosloniec, E. F., Vitez, L. J., Buus, S., and Freed, J. H. (1990). MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation. J. Exp. Med. 171, 1419-1430.
115. Rossi, D., and Zlotnik, A. (2000). The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217-243.
116. Saeki, H., Moore, A. M., Brown, M. J., and Hwang, S. T. (1999). Cutting edge: Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162, 2472-2475.
117. Saito, H., Tsujitani, S., Ikeguchi, M., Maeta, M., and Kaibara, N. (1998). Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br. J. Cancer 78, 1573-1577.
118. Sallusto, F., and Lanzavecchia, A. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-α. J. Exp. Med. 179, 1109-1118.
119. Sallusto, F., and Lanzavecchia, A. (1999). Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 189, 611-614.
120. Sato, N., Ahuja, S. K., Quinones, M., Kostecki, V., Reddick, R. L., Melby, P. C., Kuziel, W. A., and Ahuja, S. S. (2000). CC chemokine receptor (CCR) 2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, B cell outgrowth, and sustained neutrophilic inflammation. J. Exp. Med. 192, 205-218.
121. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. (2000). Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423-433.
122. Schuler-Thurner, B., Dieckmann, D., Keikavoussi, P., Bender, A., Maczek, C., Jonuleit, H., Röder, C., Haendle, I., Leisgang, W., Dunbar, R., Cerundolo, V., Von den Driesch, P., Knop, J., Bröcker, E. B., Enk, A., Kämpgen, E., and Schuler, G. (2000). Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J. Immunol. 165, 3492-3496.
123. Schuler, G. (Ed.) (1991). "Epidermal Langerhans Cells." 1 Ed. CRC Press, Inc., Boca Raton, FL.
124. Schuler, G., and Steinman, R. M. (1985). Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161, 526-546.
125. Schuler, G., and Steinman, R. M. (1997). Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186, 1183-1187.
126. Schuler, G., Romani, N., Stössel, H., and Wolff, K. (1991). Structural organization and biological properties of Langerhans cells. In "Epidermal Langerhans Cells" (G. Schuler, Ed.,) pp. 87-137. CRC Press, Inc., Boca Raton, FL.
127. Schuler, G., Thurner, B., and Romani, N. (1997). Dendritic cells: From ignored cells to major players in T-cell-mediated immunity. Int. Arch. Allergy Immunol. 112, 317-322.
128. Schwarzenberger, K., and Udey, M. C. (1996). Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106, 553-558.
129. Shapiro, S. D. (1998). Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr. Opin. Cell Biol. 10, 602-608.
130. Shortman, K. (2000). Dendritic cells: Multiple subtypes, multiple origins, multiple functions. Immunol. Cell Biol. 78, 161-165.
131. Shortman, K., and Caux, C. (1997). Dendritic cell development: Multiple pathways to nature's adjuvants. Stem Cells 15, 409-419.
132. Silberberg-Sinakin, I., Thorbecke, G. J., Baer, R. L., Rosenthal, S. A., and Berezowsky, V. (1976). Antigen-bearing Langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell. Immunol. 25, 137-151.
133. Sozzani, S., Allavena, P., Vecchi, A., and Mantovani, A. (1999). The role of chemokines in the regulation of dendritic cell trafficking. J. Leukocyte Biol. 66, 1-9.
134. Sprinzl, G. M., Hussl, B., Obrist, P., Yoneda, K., Thumfart, W. F., Romani, N., and Schrott-Fischer, A. (2000). Dendritic cells in precancerous lesions of the larynx. Laryngoscope 110, 13-18.
135. Steinman, R. M. (1998). Dendritic cells. In "Fundamental Immunology," 4 Ed. (W. E. Paul, Ed.), pp. 547-573. Lippincott-Raven, Philadelphia.
136. Steinman, R. M., Metlay, J., Bhardwaj, N., Freudenthal, P., Langhoff, E., Crowley, M., Lau, L., Witmer-Pack, M., Young, J. W., Pure, E., Romani, N., and Inaba, K. (1990). Dendritic cells: Nature's adjuvant. In "Immunogenicity" (C. A. Janeway, Jr., J. Sprent, and E. Sercarz, Eds.), Vol. 113, pp. 155-165. Alan R. Liss Inc., New York.
137. Steinman, R. M., Pack, M., and Inaba, K. (1997). Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156, 25-37.
138. Steinman, R. M., Inaba, K., Turley, S., Pierre, P., and Mellman, I. (1999). Antigen capture, processing, and presentation by dendritic cells: Recent cell biological studies. Human Immunol. 60, 562-567.
139. Steinman, R. M., Turley, S., Mellman, I., and Inaba, K. (2000). The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411-416.
140. Stoitzner, P., Zanella, M., Ortner, U., Lukas, M., Tagwerker, A., Janke, K., Lutz, M. B., Schuler, G., Echtenacher, B., Ryffel, B., Koch, F., and Romani, N. (1999). Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: Augmentation by TNF-α and IL-1β. J. Leukocyte Biol. 66, 462-470.
141. Stoitzner, P., Ratzinger, G., Koch, F., Janke, K., Schöller, T., Kaser, A., Tilg, H., Cruikshank, W. W., Fritsch, P., and Romani, N. (2001). Interleukin-16 supports the migration of Langerhans cells, partly in a CD4-independent way. J. Invest. Dermatol. in press.
142. Streilein, J. W., Toews, G. B., and Bergstresser, P. R. (1979). Corneal allografts fail to express Ia antigens. Nature 282, 326-327.
143. Streilein, J. W., Lonsberry, L. W., and Bergstresser, P. R. (1982). Depletion of epidermal Langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J. Exp. Med. 155, 863-871.
144. Strobl, H., and Knapp, W. (1999). TGF-β1 regulation of dendritic cells. Microbes Infect. 1, 1283-1290.
145. + hemopoietic progenitors. J. Immunol. 157, 1499-1507.
146. Strunk, D., Egger, C., Leitner, G., Hanau, D., and Stingl, G. (1997). A skin homing molecule defines the Langerhans cell progenitor in human peripheral blood. J. Exp. Med. 185, 1131-1136.
147. Süss, G., and Shortman, K. (1996). A subclass of dendritic cells kills CD4 T cells via Fas Fasligand-induced apoptosis. J. Exp. Med. 183, 1789-1796.
148. Tang, A., Amagai, M., Granger, L. G., Stanley, J. R., and Udey, M. C. (1993). Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature (Lond.) 361, 82-85.
149. Teunissen, M. B. M., Wormmeester, J., Krieg, S. R., Peters, P. J., Vogels, I. M. C., Kapsenberg, M. L., and Bos, J. D. (1990). Human epidermal Langerhans cells undergo profound morphological and phenotypical changes during in vitro culture. J. Invest. Dermatol. 94, 166-173.
150. Thurner, B., Haendle, I., Röder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., den Driesch, P., Bröcker, E. B., Steinman, R. M., Enk, A., Kämpgen, E., and Schuler, G. (1999). Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190, 1669-1678.
151. Timmerman, J. M., and Levy. R. (1999). Dendritic cell vaccines for cancer immunotherapy. Annu. Rev. Med. 50, 507-529.
152. Timpl, R. (1996). Macromolecular organization of basement membranes. Curr. Opin. Cell Biol. 8, 618-624.
153. Toews, G. B., Bergstresser, P. R., and Streilein, J. W. (1980). Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124, 445-453.
154. + cells are capable of initiating delayed type hypersensitivity responses. J. Invest. Dermatol. 94, 267-272.
155. Uchi, H., Imayama, S., Kobayashi, Y., and Furue, M. (1998). Langerhans cells express matrix metalloproteinase-9 in the human epidermis. J. Invest. Dermatol. 111, 1232-1233.
156. Udey, M. C. (1997). Cadherins and Langerhans cell immunobiology. Clin. Exp. Immunol. 107 (Suppl. 1), 6-8.
157. Valladeau, J., Duvert-Frances, V., Pin, J. J., Dezutter-Dambuyant, C., Vincent, C., Massacrier, C., Vincent, J., Yoneda, K., Banchereau, J., Caux, C., Davoust, J., and Saeland, S. (1999). The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 29, 2695-2704.
158. Valladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer, M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J., Caux, C., Lebecque, S., and Saeland, S. (2000). Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12, 71-81.
159. Wang, B. H., Kondo, S., Shivji, G. M., Fujisawa, H., Mak, T. W., and Sauder, D. N. (1996). Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells. Immunology 88, 284-288.
160. Wang, B. H., Fujisawa, H., Zhuang, L. H., Kondo, S., Shivji, G. M., Kim, C. S., Mak, T. W., and Sauder, D. N. (1997). Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 159, 6148-6155.
161. Wang, B. H., Zhuang, L. H., Fujisawa, H., Shinder, G. A., Feliciani, C., Shivji, G. M., Suzuki, H., Amerio, E., Toto, P., and Sauder, D. N. (1999a). Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162, 277-283.
162. Wang, B. H., Amerio, P., and Sauder, D. N. (1999b). Role of cytokines in epidermal Langerhans cell migration. J. Leukocyte Biol. 66, 33-39.
163. Wang, M., Qin, X. J., Mudgett, J. S., Ferguson, T. A., Senior, R. M., and Welgus, H. G. (1999). Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci. USA 96, 6885-6889.
164. Weinlich, G., Heine, M., Stössel, H., Zanella, M., Stoitzner, P., Ortner, U., Smolle, J., Koch, F., Sepp, N. T., Schuler, G., and Romani, N. (1998). Entry into afferent lymphatics and maturation in situ of migrating cutaneous dendritic cells. J. Invest. Dermatol. 110, 441-448.
165. Weiss, J. M., Sleeman, J., Renkl, A. C., Dittmar, H., Termeer, C. C., Taxis, S., Howells, N., Hofmann, M., Köhler, G., Schöpf, E., Ponta, H., Herrlich, P., and Simon, J. C. (1997). An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137, 1137-1147.
166. Wischatta, M., Sprinzl, G. M., Gunkel, A. R., Hussl, B., Romani, N., and Schrott-Fischer, A. (2000). Dendritic cells in selected head and neck tumors. Ann. Otol. Rhinol. Laryngol. 109, 56-62.
167. Witmer-Pack, M. D., Olivier, W., Valinsky, J., Schuler, G., and Steinman, R. M. (1987). Granulocyte/ macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166, 1484-1498.
168. Wolff, K. (1967). The fine structure of the Langerhans cell granule. J. Cell Biol. 35, 466-473.
169. Wolff, K. (1991). The fascinating story that began in 1868. In "Epidermal Langerhans Cells" (G. Schuler, Ed.), pp. 1-21. CRC Press, Inc., Boca Raton, FL.
170. Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H. L., Steinman, R. M., and Choi, Y. W. (1997). TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186, 2075-2080.
171. Wu, S. J. L., Grouard-Vogel, G., Sun, W., Mascola, J. R., Brachtel, E., Putvatana, R., Louder, M. K., Filgueira, L., Marovich, M. A., Wong, H. K., Blauvelt, A., Murphy, G. S., Robb, M. L., Innes, B. L., Birx, D. L., Hayes, C. G., and Frankel, S. S. (2000). Human skin Langerhans cells are targets of dengue virus infection. Nature Med. 6, 816-820.
172. Yanagihara, S., Komura, E., Nagafune, J., Watarai, H., and Yamaguchi, Y. (1998). EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 161, 3096-3102.
173. Zhang, Y. H., McCluskey, K., Fujii, K., and Wahl, L. M. (1998). Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-granulocyte-macrophage CSF, and IL-1 through prostaglandin-dependent and -independent mechanisms. J. Immunol. 161, 3071-3076.
174. Zinkernagel, R. M. (1996). Immunology taught by viruses. Science 271, 173-178.
175. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., Deleo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. (1996). Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183, 87-97.
176. Zlotnik, A., and Yoshie, O. (2000). Chemokines: A new classification and their role in immunity. Immunity 12, 121-127.